Table 2.
Characteristics in patients with enlarged left atrium
| Characteristics | Recurrence (n = 11) | No‐recurrence (n = 29) | P |
|---|---|---|---|
| Age (y) | 65.8 ± 9.0 | 61.2 ± 8.2 | 0.13 |
| Female | 3 (27.3) | 5 (17.2) | 0.66 |
| Long‐standing persistent AF | 7 (63.6) | 15 (51.7) | 0.72 |
| Diabetes mellitus | 2 (18.2) | 7 (24.1) | 1.0 |
| Hypertension | 6 (54.6) | 21 (72.4) | 0.45 |
| Structural heart disease | 3 (27.3) | 4 (13.8) | 0.37 |
| History of congestive heart failure | 3 (27.3) | 5 (17.2) | 0.66 |
| Plasma BNP (pg/mL) | 328 ± 710 | 161 ± 175 | 0.46 |
| CRP (mg/dL) | 0.28 ± 0.5 | 0.23 ± 0.23 | 0.76 |
| LAD (mm) | 50.6 ± 5.9 | 50.2 ± 4.6 | 0.82 |
| LVEF (%) | 62.3 ± 14.4 | 60.7 ± 10.8 | 0.71 |
| AAD | 8 (72.7) | 26 (89.7) | 0.32 |
| Beta blockers | 8 (72.7) | 21 (72.4) | 1.0 |
| Multiple sessions | 7 (63.6) | 5 (17.2) | 0.008 |
| Extra‐PVAI procedure | 10 (90.9) | 20 (69.0) | 0.23 |
| Burst pacing positive | 9 (81.8) | 13 (44.8) | 0.07 |
| Max Burst Rate (ppm) (AF noninducible) | 274 ± 49 | 294 ± 42 | 0.19 |
| ERAF | 4 (36.4) | 7 (24.1) | 0.46 |